{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:41:42Z","timestamp":1765964502722,"version":"3.48.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Ministry of Education, Culture, Research and Technology of the Republic of Indonesia, Kedaireka Matching Fund","award":["23\/E1\/PPK\/KS.03.00\/2023"],"award-info":[{"award-number":["23\/E1\/PPK\/KS.03.00\/2023"]}]},{"name":"Faculty of Medicine Universitas Diponegoro","award":["3081\/UN7.5.4.2\/PP\/2022"],"award-info":[{"award-number":["3081\/UN7.5.4.2\/PP\/2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27710-6","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:36:39Z","timestamp":1765964199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenic variants in affected and unaffected individuals from Indonesian familial cancer: a multigene panel analysis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0020-6722","authenticated-orcid":false,"given":"Muflihatul","family":"Muniroh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Hari Nawangsih","family":"Prihharsanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward Kurnia Setiawan","family":"Limijadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan Wisnu","family":"Prajoko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusril","family":"Ichzana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyadatun","family":"Nabila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Putri","family":"Setyawati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza Tri","family":"Sutrisno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ermawan","family":"Teguh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Rusdan H.","family":"Utomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"27710_CR1","unstructured":"WHO. Global cancer burden growing, amidst mounting need for services. Available from https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services. (2024) Accessed 11 May 2024"},{"issue":"8","key":"27710_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nat. Med. 10(8), 789\u2013799. https:\/\/doi.org\/10.1038\/nm1087 (2004).","journal-title":"Nat. Med."},{"key":"27710_CR3","unstructured":"Institute, N. C. Dictionary of cancer terms. Available from https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/familial-cancer. (2025) Accessed 21 Oct 2025"},{"issue":"17","key":"27710_CR4","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.3390\/cancers13174385","volume":"13","author":"K Hemminki","year":"2021","unstructured":"Hemminki, K. et al. Familial risks and proportions describing population landscape of familial cancer. Cancers (Basel) 13(17), 4385. https:\/\/doi.org\/10.3390\/cancers13174385 (2021).","journal-title":"Cancers (Basel)"},{"key":"27710_CR5","doi-asserted-by":"publisher","first-page":"107327482110534","DOI":"10.1177\/10732748211053464","volume":"28","author":"H Puspitaningtyas","year":"2021","unstructured":"Puspitaningtyas, H., Espressivo, A., Hutajulu, S. H., Fuad, A. & Allsop, M. J. Mapping and visualization of cancer research in Indonesia: A scientometric analysis. Cancer Control 28, 10732748211053464. https:\/\/doi.org\/10.1177\/10732748211053464 (2021).","journal-title":"Cancer Control"},{"key":"27710_CR6","unstructured":"Ferlay, J., Ervik, M., Lam, F., Laversanne, M., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., & Bray, F. Global Cancer Observatory: Cancer Today. Available from https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/360-indonesia-fact-sheet.pdf. (2024) Accessed 11 May 2024"},{"issue":"1","key":"27710_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13053-023-00247-3","volume":"21","author":"K Hemminki","year":"2023","unstructured":"Hemminki, K., Li, X., F\u00f6rsti, A. & Eng, C. Are population level familial risks and germline genetics meeting each other?. Hered. Cancer Clin. Pract. 21(1), 3. https:\/\/doi.org\/10.1186\/s13053-023-00247-3 (2023).","journal-title":"Hered. Cancer Clin. Pract."},{"issue":"2","key":"27710_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5306\/wjco.v14.i2.40","volume":"14","author":"EN Imyanitov","year":"2023","unstructured":"Imyanitov, E. N. et al. Hereditary cancer syndromes. World J. Clin. Oncol. 14(2), 40\u201368. https:\/\/doi.org\/10.5306\/wjco.v14.i2.40 (2023).","journal-title":"World J. Clin. Oncol."},{"key":"27710_CR9","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.2147\/cmar.S206817","volume":"11","author":"M Ashour","year":"2019","unstructured":"Ashour, M. & Ezzat Shafik, H. Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome. Cancer Manag. Res. 11, 6275\u20136284. https:\/\/doi.org\/10.2147\/cmar.S206817 (2019).","journal-title":"Cancer Manag. Res."},{"key":"27710_CR10","unstructured":"NCCN. Clinical practice guidelines in oncology, breast cancer. Version 4.2022. . Retrieved from https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. (2022)"},{"key":"27710_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/tacg.S35605","volume":"6","author":"DG Evans","year":"2013","unstructured":"Evans, D. G. & Ingham, S. L. Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors. Appl. Clin. Genet. 6, 53\u201361. https:\/\/doi.org\/10.2147\/tacg.S35605 (2013).","journal-title":"Appl. Clin. Genet."},{"issue":"4","key":"27710_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5152\/ejbh.2018.4324","volume":"14","author":"I Jatoi","year":"2018","unstructured":"Jatoi, I. Risk-reducing options for women with a hereditary breast cancer predisposition. Eur. J. Breast Health 14(4), 189\u2013193. https:\/\/doi.org\/10.5152\/ejbh.2018.4324 (2018).","journal-title":"Eur. J. Breast Health"},{"key":"27710_CR13","doi-asserted-by":"publisher","unstructured":"Auton, A. et al. A global reference for human genetic variation. Nature 526(7571): 68\u201374 https:\/\/doi.org\/10.1038\/nature15393(2015)","DOI":"10.1038\/nature15393"},{"issue":"5","key":"27710_CR14","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ajhg.2020.09.011","volume":"107","author":"LM Amendola","year":"2020","unstructured":"Amendola, L. M. et al. Variant classification concordance using the ACMG-AMP variant interpretation guidelines across nine genomic implementation research studies. Am. J. Hum. Genet. 107(5), 932\u2013941. https:\/\/doi.org\/10.1016\/j.ajhg.2020.09.011 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"27710_CR15","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.1200\/JCO.2023.41.16_suppl.10510","volume":"41","author":"ZK Stadler","year":"2023","unstructured":"Stadler, Z. K. et al. Redefining early-onset cancer and risk of hereditary cancer predisposition. J. Clin. Oncol. 41, 10510. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.10510 (2023).","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"27710_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","volume":"18","author":"LR Susswein","year":"2016","unstructured":"Susswein, L. R. et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing. Genet. Med. 18(8), 823\u2013832. https:\/\/doi.org\/10.1038\/gim.2015.166 (2016).","journal-title":"Genet. Med."},{"key":"27710_CR17","unstructured":"National Cancer Institute. The Genetics of Cancer. Available from https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/genetics#:~:text=Up%20to%2010%25%20of%20all,of%20getting%20cancer%20is%20increased. (2024)"},{"key":"27710_CR18","unstructured":"Canadian Cancer Society. Check your family history. Available from https:\/\/cancer.ca\/en\/cancer-information\/reduce-your-risk\/check-your-family-history#:~:text=When%20there%20is%20cancer%20in,than%20one%20type%20of%20cancer. (2025)"},{"issue":"3","key":"27710_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ophtha.2017.09.001","volume":"125","author":"AH Skalet","year":"2018","unstructured":"Skalet, A. H. et al. Screening children at risk for retinoblastoma: consensus report from the American association of ophthalmic oncologists and pathologists. Ophthalmology 125(3), 453\u2013458. https:\/\/doi.org\/10.1016\/j.ophtha.2017.09.001 (2018).","journal-title":"Ophthalmology"},{"issue":"12","key":"27710_CR20","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1038\/bjc.2013.228","volume":"108","author":"A MacCarthy","year":"2013","unstructured":"MacCarthy, A. et al. Second and subsequent tumours among 1927 retinoblastoma patients diagnosed in Britain 1951\u20132004. Br. J. Cancer 108(12), 2455\u20132463. https:\/\/doi.org\/10.1038\/bjc.2013.228 (2013).","journal-title":"Br. J. Cancer"},{"key":"27710_CR21","doi-asserted-by":"publisher","unstructured":"Li, S. et al. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. J. Clin. Oncol., 40(14): 1529\u20131541 https:\/\/doi.org\/10.1200\/jco.21.02112(2022)","DOI":"10.1200\/jco.21.02112"},{"issue":"7","key":"27710_CR22","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1200\/jco.19.01907","volume":"38","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families. J. Clin. Oncol. 38(7), 674\u2013685. https:\/\/doi.org\/10.1200\/jco.19.01907 (2020).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"27710_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.48095\/ccko202126","volume":"34","author":"J Soukupov\u00e1","year":"2021","unstructured":"Soukupov\u00e1, J. et al. Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer. Klin. Onkol. 34(1), 26\u201332. https:\/\/doi.org\/10.48095\/ccko202126 (2021).","journal-title":"Klin. Onkol."},{"key":"27710_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejca.2022.12.011","volume":"182","author":"STC Shepherd","year":"2023","unstructured":"Shepherd, S. T. C., Drake, W. M. & Turajlic, S. The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet?. Eur. J. Cancer 182, 15\u201322. https:\/\/doi.org\/10.1016\/j.ejca.2022.12.011 (2023).","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"27710_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/genes14051025","volume":"14","author":"M Garutti","year":"2023","unstructured":"Garutti, M. et al. Hereditary cancer syndromes: A comprehensive review with a visual tool. Genes (Basel) 14(5), 1025. https:\/\/doi.org\/10.3390\/genes14051025 (2023).","journal-title":"Genes (Basel)"},{"issue":"8","key":"27710_CR26","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1002\/cncr.26506","volume":"118","author":"G Rennert","year":"2012","unstructured":"Rennert, G. et al. MutYH mutation carriers have increased breast cancer risk. Cancer 118(8), 1989\u20131993. https:\/\/doi.org\/10.1002\/cncr.26506 (2012).","journal-title":"Cancer"},{"issue":"1","key":"27710_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41421-023-00614-3","volume":"9","author":"C Chen","year":"2023","unstructured":"Chen, C. et al. Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities. Cell Discov. 9(1), 125. https:\/\/doi.org\/10.1038\/s41421-023-00614-3 (2023).","journal-title":"Cell Discov."},{"issue":"1","key":"27710_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/diagnostics11010084","volume":"11","author":"ML Hutchcraft","year":"2021","unstructured":"Hutchcraft, M. L., Gallion, H. H. & Kolesar, J. M. MUTYH as an emerging predictive biomarker in ovarian cancer. Diagnostics (Basel) 11(1), 84. https:\/\/doi.org\/10.3390\/diagnostics11010084 (2021).","journal-title":"Diagnostics (Basel)"},{"issue":"12","key":"27710_CR29","doi-asserted-by":"publisher","first-page":"104359","DOI":"10.1016\/j.ejmg.2021.104359","volume":"64","author":"HQ Rana","year":"2021","unstructured":"Rana, H. Q. et al. Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results. Eur. J. Med. Genet. 64(12), 104359. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104359 (2021).","journal-title":"Eur. J. Med. Genet."},{"issue":"4","key":"27710_CR30","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.18632\/oncotarget.23470","volume":"9","author":"SE Scanlon","year":"2018","unstructured":"Scanlon, S. E., Hegan, D. C., Sulkowski, P. L. & Glazer, P. M. Suppression of homology-dependent DNA double-strand break repair induces PARP inhibitor sensitivity in VHL-deficient human renal cell carcinoma. Oncotarget 9(4), 4647\u20134660. https:\/\/doi.org\/10.18632\/oncotarget.23470 (2018).","journal-title":"Oncotarget"},{"issue":"10","key":"27710_CR31","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1245\/s10434-017-5963-7","volume":"24","author":"E O'Leary","year":"2017","unstructured":"O\u2019Leary, E. et al. Expanded gene panel use for women with breast cancer: identification and intervention beyond breast cancer risk. Ann. Surg. Oncol. 24(10), 3060\u20133066. https:\/\/doi.org\/10.1245\/s10434-017-5963-7 (2017).","journal-title":"Ann. Surg. Oncol."},{"key":"27710_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkab044","author":"X Fan","year":"2021","unstructured":"Fan, X. et al. Penetrance of breast cancer susceptibility genes from the eMERGE III network. JNCI Cancer Spectr. https:\/\/doi.org\/10.1093\/jncics\/pkab044 (2021).","journal-title":"JNCI Cancer Spectr."},{"key":"27710_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.critrevonc.2016.10.008","volume":"108","author":"C van Marcke","year":"2016","unstructured":"van Marcke, C., De Leener, A., Berli\u00e8re, M., Vikkula, M. & Duhoux, F. P. Routine use of gene panel testing in hereditary breast cancer should be performed with caution. Crit. Rev. Oncol. Hematol. 108, 33\u201339. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.10.008 (2016).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"27710_CR34","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1245\/s10434-021-10870-w","volume":"29","author":"A Mittal","year":"2022","unstructured":"Mittal, A. et al. Profile of pathogenic mutations and evaluation of germline genetic testing criteria in consecutive breast cancer patients treated at a North Indian tertiary care center. Ann. Surg. Oncol. 29(2), 1423\u20131432. https:\/\/doi.org\/10.1245\/s10434-021-10870-w (2022).","journal-title":"Ann. Surg. Oncol."},{"issue":"29","key":"27710_CR35","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1038\/onc.2008.42","volume":"27","author":"V Gouyer","year":"2008","unstructured":"Gouyer, V. et al. Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells. Oncogene 27(29), 4024\u20134033. https:\/\/doi.org\/10.1038\/onc.2008.42 (2008).","journal-title":"Oncogene"},{"key":"27710_CR36","doi-asserted-by":"publisher","unstructured":"Enjuto, D. T., Herrera, N., C, J. C., Ramos Bonilla, A., Llorente-L\u00e1zaro, R., Gonz\u00e1lez Guerreiro, J., & Castro-Carbajo, P. Hereditary Pancreatitis Related to SPINK-1 Mutation. Is There an Increased Risk of Developing Pancreatic Cancer?. J. Gastrointest. Cancer, 54(1): 268\u2013269. https:\/\/doi.org\/10.1007\/s12029-021-00729-4(2023)","DOI":"10.1007\/s12029-021-00729-4"},{"issue":"6","key":"27710_CR37","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1210\/jc.2011-3299","volume":"97","author":"L Xu","year":"2012","unstructured":"Xu, L., Morari, E. C., Wei, Q., Sturgis, E. M. & Ward, L. S. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 97(6), 1913\u20131921. https:\/\/doi.org\/10.1210\/jc.2011-3299 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"27710_CR38","doi-asserted-by":"publisher","unstructured":"Petersen, L., & Bebb, D. G. P1.02\u2013086 ATM mutations in lung cancer correlate to higher mutation rates: topic: other mutations in thoracic malignancies. J. Thoracic Oncol. 12(1): S541. https:\/\/doi.org\/10.1016\/j.jtho.2016.11.670(2017)","DOI":"10.1016\/j.jtho.2016.11.670"},{"issue":"1","key":"27710_CR39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12957-024-03553-9","volume":"22","author":"M Pal","year":"2024","unstructured":"Pal, M., Das, D. & Pandey, M. Understanding genetic variations associated with familial breast cancer. World J. Surg. Oncol. 22(1), 271. https:\/\/doi.org\/10.1186\/s12957-024-03553-9 (2024).","journal-title":"World J. Surg. Oncol."},{"key":"27710_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036541","author":"J Schienda","year":"2020","unstructured":"Schienda, J. & Stopfer, J. Cancer genetic counseling-current practice and future challenges. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a036541 (2020).","journal-title":"Cold Spring Harb. Perspect. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27710-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27710-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T09:36:42Z","timestamp":1765964202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27710-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27710"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27710-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"24 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no potential conflicts of interest concerning this article\u2019s research, authorship, and\/or publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the World Medical Association Ethics Code (Declaration of Helsinki). All research procedures were carried out in accordance with relevant laws and institutional guidelines. The Health Research Ethics Committee issued the ethical approval, Dr. Kariadi Central General Hospital Semarang, number 1489\/EC\/KEPK-RSDK\/2023.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all study subjects before conducting the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}],"article-number":"43981"}}